Will microorganisms become the second Hengrui Pharmaceutical?

I will. First of all, unlike Hengrui Pharmaceutical, core-fed organisms mainly seek new targets and develop new mechanisms of action, thus making revolutionary breakthroughs. 2. The company's senior management team, academic experience, results management, professional background and rich experience. The ownership structure is relatively stable, and the layout of intellectual property rights is directly aimed at global development. 22/kloc-0 global invention patents have been applied, of which 79 are authorized. 3. The core product-Chidamei's revenue grew steadily. All these doomed it to be the second Hengrui Pharmaceutical.